Identifican cómo el cáncer de ovario se vuelve resistente a la quimioterapia

Scientists uncover how ovarian cancer resists chemotherapy—and how to reverse it

Researchers identified TPPP3 protein driving cisplatin resistance in ovarian cancer; blocking it restores drug sensitivity and predicts treatment outcomes. This enables TPPP3-targeted therapies and biomarker-guided personalization, improving existing chemotherapy efficacy rather than requiring new agents.